Clinical Trial Update: Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children. [Phase 3]

View source ↗

Summary

Extension study update for fesoterodine in children with overactive bladder, Phase 3, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Fesoterodine (fesoterodine)

Snippet

Sponsor: Stéphane Bolduc | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED